Correlation Between VTv Therapeutics and Boundless Bio,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VTv Therapeutics and Boundless Bio, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VTv Therapeutics and Boundless Bio, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between vTv Therapeutics and Boundless Bio, Common, you can compare the effects of market volatilities on VTv Therapeutics and Boundless Bio, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VTv Therapeutics with a short position of Boundless Bio,. Check out your portfolio center. Please also check ongoing floating volatility patterns of VTv Therapeutics and Boundless Bio,.

Diversification Opportunities for VTv Therapeutics and Boundless Bio,

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between VTv and Boundless is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding vTv Therapeutics and Boundless Bio, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Boundless Bio, Common and VTv Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on vTv Therapeutics are associated (or correlated) with Boundless Bio,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Boundless Bio, Common has no effect on the direction of VTv Therapeutics i.e., VTv Therapeutics and Boundless Bio, go up and down completely randomly.

Pair Corralation between VTv Therapeutics and Boundless Bio,

Given the investment horizon of 90 days VTv Therapeutics is expected to generate 2.03 times less return on investment than Boundless Bio,. But when comparing it to its historical volatility, vTv Therapeutics is 1.57 times less risky than Boundless Bio,. It trades about 0.08 of its potential returns per unit of risk. Boundless Bio, Common is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  235.00  in Boundless Bio, Common on September 23, 2024 and sell it today you would earn a total of  24.00  from holding Boundless Bio, Common or generate 10.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

vTv Therapeutics  vs.  Boundless Bio, Common

 Performance 
       Timeline  
vTv Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in vTv Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, VTv Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Boundless Bio, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Boundless Bio, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

VTv Therapeutics and Boundless Bio, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VTv Therapeutics and Boundless Bio,

The main advantage of trading using opposite VTv Therapeutics and Boundless Bio, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VTv Therapeutics position performs unexpectedly, Boundless Bio, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boundless Bio, will offset losses from the drop in Boundless Bio,'s long position.
The idea behind vTv Therapeutics and Boundless Bio, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk